Kinetic Modeling of Stem Cell Transcriptome Dynamics to Identify Regulatory Modules of Normal and Disturbed Neuroectodermal Differentiation

Overview

Journal Nucleic Acids Res

Publisher Oxford University Press

Specialty Biochemistry

Date 2020 Nov 27

PMID 33245762

Citations 7

Authors

Johannes Meisig

Nadine Dreser

Marion Kapitza

Margit Henry

Tamara Rotshteyn

Jorg Rahnenfuhrer

Jan G Hengstler

Agapios Sachinidis

Tanja Waldmann

Marcel Leist

Nils Bluthgen

Affiliations

Soon will be listed here.

Abstract

Thousands of transcriptome data sets are available, but approaches for their use in dynamic cell response modelling are few, especially for processes affected simultaneously by two orthogonal influencing variables. We approached this problem for neuroepithelial development of human pluripotent stem cells (differentiation variable), in the presence or absence of valproic acid (signaling variable). Using few basic assumptions (sequential differentiation states of cells; discrete on/off states for individual genes in these states), and time-resolved transcriptome data, a comprehensive model of spontaneous and perturbed gene expression dynamics was developed. The model made reliable predictions (average correlation of 0.85 between predicted and subsequently tested expression values). Even regulations predicted to be non-monotonic were successfully validated by PCR in new sets of experiments. Transient patterns of gene regulation were identified from model predictions. They pointed towards activation of Wnt signaling as a candidate pathway leading to a redirection of differentiation away from neuroepithelial cells towards neural crest. Intervention experiments, using a Wnt/beta-catenin antagonist, led to a phenotypic rescue of this disturbed differentiation. Thus, our broadly applicable model allows the analysis of transcriptome changes in complex time/perturbation matrices.

Citing Articles

Sex-biased gene expression during neural differentiation of human embryonic stem cells.

Pottmeier P, Nikolantonaki D, Lanner F, Peuckert C, Jazin E Front Cell Dev Biol. 2024; 12:1341373.

PMID: 38764741 PMC: 11101176. DOI: 10.3389/fcell.2024.1341373.

Transcriptome-based prediction of drugs, inhibiting cardiomyogenesis in human induced pluripotent stem cells.

Cherianidou A, Kappenberg F, Seidel F, Acharya A, Papazoglou P, Srinivasan S Cell Death Discov. 2023; 9(1):321.

PMID: 37644023 PMC: 10465524. DOI: 10.1038/s41420-023-01616-6.

G × E interactions as a basis for toxicological uncertainty.

Suciu I, Pamies D, Peruzzo R, Wirtz P, Smirnova L, Pallocca G Arch Toxicol. 2023; 97(7):2035-2049.

PMID: 37258688 PMC: 10256652. DOI: 10.1007/s00204-023-03500-9.

High Accuracy Classification of Developmental Toxicants by In Vitro Tests of Human Neuroepithelial and Cardiomyoblast Differentiation.

Seidel F, Cherianidou A, Kappenberg F, Marta M, Dreser N, Blum J Cells. 2022; 11(21).

PMID: 36359802 PMC: 9653768. DOI: 10.3390/cells11213404.

Pluripotent stem cell assays: Modalities and applications for predictive developmental toxicity.

Piersma A, Baker N, Daston G, Flick B, Fujiwara M, Knudsen T Curr Res Toxicol. 2022; 3:100074.

PMID: 35633891 PMC: 9130094. DOI: 10.1016/j.crtox.2022.100074.

References

La Manno G, Soldatov R, Zeisel A, Braun E, Hochgerner H, Petukhov V . RNA velocity of single cells. Nature. 2018; 560(7719):494-498. PMC: 6130801. DOI: 10.1038/s41586-018-0414-6. View

Honkela A, Girardot C, Gustafson E, Liu Y, Furlong E, Lawrence N . Model-based method for transcription factor target identification with limited data. Proc Natl Acad Sci U S A. 2010; 107(17):7793-8. PMC: 2867914. DOI: 10.1073/pnas.0914285107. View

Marchetto M, Narvaiza I, Denli A, Benner C, Lazzarini T, Nathanson J . Differential L1 regulation in pluripotent stem cells of humans and apes. Nature. 2013; 503(7477):525-529. PMC: 4064720. DOI: 10.1038/nature12686. View

Chanda S, Ang C, Lee Q, Ghebrial M, Haag D, Shibuya Y . Direct Reprogramming of Human Neurons Identifies MARCKSL1 as a Pathogenic Mediator of Valproic Acid-Induced Teratogenicity. Cell Stem Cell. 2019; 25(1):103-119.e6. PMC: 6609489. DOI: 10.1016/j.stem.2019.04.021. View

Bessonnard S, de Mot L, Gonze D, Barriol M, Dennis C, Goldbeter A . Gata6, Nanog and Erk signaling control cell fate in the inner cell mass through a tristable regulatory network. Development. 2014; 141(19):3637-48. DOI: 10.1242/dev.109678. View

Dragunow M . The adult human brain in preclinical drug development. Nat Rev Drug Discov. 2008; 7(8):659-66. DOI: 10.1038/nrd2617. View

Chambers S, Fasano C, Papapetrou E, Tomishima M, Sadelain M, Studer L . Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 2009; 27(3):275-80. PMC: 2756723. DOI: 10.1038/nbt.1529. View

Omtzigt J, Los F, Grobbee D, Pijpers L, Jahoda M, Brandenburg H . The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology. 1992; 42(4 Suppl 5):119-25. View

Chickarmane V, Peterson C . A computational model for understanding stem cell, trophectoderm and endoderm lineage determination. PLoS One. 2008; 3(10):e3478. PMC: 2566811. DOI: 10.1371/journal.pone.0003478. View

10.

Bentue-Ferrer D, Tribut O, Verdier M . [Therapeutic drug monitoring of valproate]. Therapie. 2010; 65(3):233-40. DOI: 10.2515/therapie/2010029. View

11.

Balmer N, Klima S, Rempel E, Ivanova V, Kolde R, Weng M . From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014; 88(7):1451-68. PMC: 4067541. DOI: 10.1007/s00204-014-1279-6. View

12.

Mica Y, Lee G, Chambers S, Tomishima M, Studer L . Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hESCs and patient-specific iPSCs. Cell Rep. 2013; 3(4):1140-52. PMC: 3681528. DOI: 10.1016/j.celrep.2013.03.025. View

13.

Qin L, Dai X, Yin Y . Valproic acid exposure sequentially activates Wnt and mTOR pathways in rats. Mol Cell Neurosci. 2016; 75:27-35. DOI: 10.1016/j.mcn.2016.06.004. View

14.

Zimmer B, Kuegler P, Baudis B, Genewsky A, Tanavde V, Koh W . Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing. Cell Death Differ. 2010; 18(3):383-95. PMC: 3131999. DOI: 10.1038/cdd.2010.109. View

15.

Dunn S, Martello G, Yordanov B, Emmott S, Smith A . Defining an essential transcription factor program for naïve pluripotency. Science. 2014; 344(6188):1156-1160. PMC: 4257066. DOI: 10.1126/science.1248882. View

16.

Farrell J, Wang Y, Riesenfeld S, Shekhar K, Regev A, Schier A . Single-cell reconstruction of developmental trajectories during zebrafish embryogenesis. Science. 2018; 360(6392). PMC: 6247916. DOI: 10.1126/science.aar3131. View

17.

Krug A, Kolde R, Gaspar J, Rempel E, Balmer N, Meganathan K . Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2012; 87(1):123-43. PMC: 3535399. DOI: 10.1007/s00204-012-0967-3. View

18.

Blotiere P, Raguideau F, Weill A, Elefant E, Perthus I, Goulet V . Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs. Neurology. 2019; 93(2):e167-e180. PMC: 6656651. DOI: 10.1212/WNL.0000000000007696. View

19.

Barenco M, Brewer D, Papouli E, Tomescu D, Callard R, Stark J . Dissection of a complex transcriptional response using genome-wide transcriptional modelling. Mol Syst Biol. 2009; 5:327. PMC: 2795478. DOI: 10.1038/msb.2009.84. View

20.

Yoo Y, Huang C, Zhang X, Lavaute T, Zhang S . Fibroblast growth factor regulates human neuroectoderm specification through ERK1/2-PARP-1 pathway. Stem Cells. 2011; 29(12):1975-82. PMC: 3229919. DOI: 10.1002/stem.758. View